Trial Profile
A Phase 0 Exploratory Study evaluating safety and pharmacokinetics of [18F]JNJ-067 in Healthy Volunteers and Subjects with Probably Alzheimer's Disease
Status:
Not stated
Phase of Trial:
Phase 0
Latest Information Update: 04 Oct 2018
Price :
$35
*
At a glance
- Drugs JNJ-067 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Pharmacokinetics
- 04 Oct 2018 New trial record